General Information

Cora Therapeutics Inc.

	Address	200 Bay Street Suite 2800 Toronto, M5J 2J3 Canada
	Address type	Registered Office Address
	Address province	Ontario

	Corporation ID	9165878
	Business number	824310965
	Status	Active
	ACT	Canada Business Corporations Act
	Anniversary date	04/29/2015
	Last annual filing	2026
	Data verified	10/31/2026

Description

Cora Therapeutics Inc. is an active enterprise registered under Canada Business Corporations Act with a corporation number 9165878 (business no 824310965). The amendment was completed on 2018-09-19. The company is located in Toronto at 200 Bay Street, Suite 2800, M5J 2J3 in Ontario area.
Additional companies in the proximity include: Macquarie Securities Financing Ltd. (Canada), James Hardie Building Products Canada Inc., 3167488 Canada Inc., Macquarie Technology Services (Canada) Ltd., Macquarie New World Gaming Canada Ltd..

Approximate location (postal code area): GeoNames (CC BY 4.0).

Company names

Name	Effective date	Type	Current
9165878 CANADA INC.	04/29/2015	Corporate Name
Cora Therapeutics Inc.	11/02/2026	Corporate Name	true

Directors

Cameron Piron
,

Rohit Parekh
,

Ashok Joshi
,

Dr. Kieran Murphy
,

last updated: 2026-10-30

Government Grants and Contributions

3 federal grants and contributions in 2020 with a total value of $90,027.

Start date	Department and program	Value
12/20/2020	National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2.5 The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.	$16,257
06/25/2020	National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2	$43,278
04/01/2020	National Research Council Canada Innovation Assistance Program (contribution) The funding provided from the IAP program is to assist innovative, early stage small-and-medium-sized enterprises that are unable to access existing COVID-19 business support.	$30,492

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date	Type	Section
02/14/2020	Amendment	6
09/19/2018	Amendment	6
04/29/2015	Incorporation